Skip to content

Acute Neuroimmune Effects of Alcohol Using Free Water Imaging

Acute Neuroimmune Effects of Alcohol Using Free Water Imaging

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03370783
Enrollment
25
Registered
2017-12-12
Start date
2017-03-31
Completion date
2017-09-28
Last updated
2022-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Drinking

Brief summary

This study examines the effects of moderate alcohol intake on the brain, the immune system, and cognition.

Detailed description

The study involves a within-subjects, pre/post design to assess the effects of a moderate dose of alcohol on immune biomarkers, neurobiological measures, and cognitive functioning. The study recruits healthy adults (ages 21-45) from the community to complete the experimental protocol. Participants complete magnetic resonance imaging scans, blood sample collection, and cognitive testing in the context of alcohol consumption.

Interventions

DRUGEthanol

Moderate alcohol consumption

Sponsors

National Institute of General Medical Sciences (NIGMS)
CollaboratorNIH
Brown University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
21 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Ages 21-45 years * Able to speak and read English at least at 8th grade level * Moderate self-reported alcohol use in the past year * Body mass index in normal to overweight range * Right-handed

Exclusion criteria

* History of heavy drinking * Currently seeking alcohol or drug treatment * Chronic disease requiring use of medication * Recent antibiotic or probiotic use * Chronic daily use of NSAIDs * Chronic GI disorder * Use of illicit drugs * Major psychiatric disorder or suicidality * Fainting, weakness, infection, excessive bruising, or distress resulting from standard blood draw * Safety contraindication for MRI scan * Inability to abstain from use of tobacco products prior to or during study * Inability to abstain from use of cannabis prior to or during study * Pregnant, nursing, or may become pregnant

Design outcomes

Primary

MeasureTime frame
Immune biomarkers1-3 hours after alcohol intake

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026